Roberts M Scot's Form 4 filing
Altimmune, Inc. (ALT) · filed Jun 28, 2022
- Accession no.
- 0001104659-22-075361
- Filed
- Jun 28, 2022
- Trade date
- Jun 27, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $448.2K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Roberts M ScotCIK 0001705905 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 27, 2022 | Common Stock, par value $0.0001 | MOption exerciseAcquired | +25,583 | $1.92 | +$49,119.36 | 43,283 | Direct | |
| Jun 27, 2022 | Common Stock, par value $0.0001 | MOption exerciseAcquired | +11,769 | $2.60 | +$30,599.4 | 55,052 | Direct | |
| Jun 27, 2022 | Common Stock, par value $0.0001 | SSaleDisposed | −37,352 | $12.00 | −$448,224 | 17,700 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 27, 2022 | Common Stock, par value $0.0001 | MOption exerciseDisposed | −61,400 | $0.00 | $0 | 35,817 | Direct | |
| Jun 27, 2022 | Common Stock, par value $0.0001 | MOption exerciseDisposed | −30,000 | $0.00 | $0 | 18,231 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.